NCT00956280View on ClinicalTrials.gov

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Non Small Cell Lung Cancer
Trial Locations (5)

Unknown

Research Site, Belo Horizonte

Research Site, Porto Alegre

Research Site, Rio de Janeiro

Research Site, Santo André

Research Site, São Paulo

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

Laboratorio Progenetica
All Listed Sponsors
collaborator

Laboratorio Progenetica

UNKNOWN

lead

AstraZeneca

INDUSTRY